Adverse effect profile with low-dose methotrexate therapy in patients suffering with rheumatic diseases
Background: Methotrexate (MTX) is the anchor drug for the management of many systemic inflammatory diseases. High-dose MTX is associated with various toxicities which may lead to drug discontinuation or interruption of therapy. Low-dose MTX is widely used for treating various systemic autoimmune dis...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Eldaghayes Publisher
2024-05-01
|
| Серии: | National Journal of Physiology, Pharmacy and Pharmacology |
| Предметы: | |
| Online-ссылка: | http://www.ejmanager.com/fulltextpdf.php?mno=166253 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
